Background Interstitial lung disease is a known complication of rheumatoid arthritis, with a
lifetime risk of developing the disease in any individual of 7·7%. We aimed to assess the safety…

Importance There is a major need for effective, well-tolerated treatments for idiopathic
pulmonary fibrosis (IPF). Objective To assess the efficacy and safety of the autotaxin inhibitor …

Background Progressive fibrosing interstitial lung disease (PF-ILD) is characterised by
progressive physiological, symptomatic and/or radiographic worsening. The real-world …

Rationale: Patients commonly use the Internet as a resource for health information; however,
no studies have evaluated the online information about idiopathic pulmonary fibrosis (IPF). …

Acute exacerbation of interstitial lung disease (ILD) is associated with a poor prognosis and
high mortality. Numerous studies have documented acute exacerbation in idiopathic …

… Fisher MD g , Nathan Hambly MD h , Martin Kolb MD h , Julie Morisset MD i , Shane
Shapera MD g , Christopher J. Ryerson MD a b … Shapera, T. To, TK Marras, A. Gershon, S. …

PBI-4050 is a novel orally active small-molecule compound with demonstrated anti-fibrotic
activity in several models of fibrosis, including lung fibrosis. We present results from our first …

Surgical volume–outcome relationships are well established but have not been studied in
patients with interstitial lung disease (ILD) undergoing surgical lung biopsy (SLB). Our study …

Introduction The purpose of this study was to determine the impact of interstitial lung disease
(ILD) on radiation pneumonitis (RP) and overall survival (OS) in lung stereotactic body …

Background Gastroesophageal reflux (GER) is common in patients with idiopathic pulmonary
fibrosis (IPF) and has been proposed as a potential contributor to disease progression and …